Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin… Grant US-11925626-B2 United States of America 12 Mar 2024
Glucocorticoid receptor modulators to treat cervical cancer Grant US-11660295-B2 United States of America 30 May 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-11648245-B2 United States of America 16 May 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-11576907-B2 United States of America 14 Feb 2023
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin… Grant US-11464764-B2 United States of America 11 Oct 2022
Methods of treating cancer comprising administration of a glucocorticoid receptor… Grant US-11389432-B2 United States of America 19 Jul 2022
Methods of treating cancer comprising administration of a glucocorticoid receptor… Grant US-11234971-B2 United States of America 01 Feb 2022
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Grant US-10973813-B2 United States of America 13 Apr 2021
Glucocorticoid receptor modulators to treat cervical cancer Grant US-10898478-B2 United States of America 26 Jan 2021
Glucocorticoid receptor modulators to treat cervical cancer Grant US-10568880-B2 United States of America 25 Feb 2020
Glucocorticoid receptor modulators to treat cervical cancer Grant US-10413540-B2 United States of America 17 Sep 2019